You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 25, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2020039263


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2020039263

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 16, 2039 Azurity MYHIBBIN mycophenolate mofetil
⤷  Start Trial Aug 16, 2039 Azurity MYHIBBIN mycophenolate mofetil
⤷  Start Trial Aug 16, 2039 Azurity MYHIBBIN mycophenolate mofetil
⤷  Start Trial Aug 16, 2039 Azurity MYHIBBIN mycophenolate mofetil
⤷  Start Trial Aug 16, 2039 Azurity MYHIBBIN mycophenolate mofetil
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claim Analysis of WIPO Patent WO2020039263

Last updated: February 20, 2026

What Is the Scope of WO2020039263?

WO2020039263 is a World Intellectual Property Organization (WIPO) patent application published on March 19, 2020. Its claims suggest a focus on a novel pharmaceutical composition or method, likely involving an active ingredient, formulation, or delivery mechanism, aimed at addressing a specific therapeutic need.

The application typically covers:

  • Target pharmaceutical indication: Likely related to a disease or condition with unmet medical needs.
  • Active compounds or formulations: Specific molecules, derivatives, or combinations.
  • Method of treatment: Administration methods, dosing regimens, or delivery systems.
  • Use claims: New therapeutic applications of known molecules.

The scope's breadth depends on the claims' language, which details the therapeutic targets, chemical structures, formulations, or uses.

How Broad Are the Claims?

The claim set's breadth influences patent strength and freedom-to-operate considerations.

  • Core claims: Usually cover the main invention, potentially including a novel compound or formulation.
  • Dependent claims: Add specific limitations, refining the scope.
  • Use claims: Cover specific therapeutic indications or methods.

Initial broad claims may encompass general formulations, while narrower dependent claims specify particular chemical structures or delivery routes. A typical WO application balances broad claim coverage with sufficient specificity to avoid prior art invalidation.

Patent Family and Related Applications

The application is likely part of a patent family, with counterparts filed in jurisdictions such as the US, Europe, China, Japan, and others. Patent family members may vary in scope, claims, and even claims language, depending on jurisdiction-specific patent laws.

  • Citations: The application cites prior art, including previous patents, scientific publications, and known compounds.
  • Priority date: The earliest filing date, critical for establishing novelty and inventive step.

Patent Landscape and Competitors

The landscape for such inventions involves:

  • Major pharmaceutical companies: Active in therapeutic areas like oncology, neurology, or infectious diseases.
  • Research institutions: Often file early-stage patents related to new compounds.
  • Patent filings in relevant jurisdictions: US, Europe, China, Japan, Korea, India, etc.

The number of filings related to similar compounds or therapeutic methods indicates crowdedness or novelty.

Prior Art and Novelty

Critical prior art includes:

  • Existing patents on similar chemical structures.
  • Published scientific literature describing comparable methods or uses.
  • Public disclosures prior to the patent application's priority date.

The application claims novelty over prior art by emphasizing specific structures, combinations, or uses not previously disclosed.

Patentability: Novelty, Inventive Step, and Industrial Applicability

  • Novelty: Claims specify features not present in prior art.
  • Inventive step: The application demonstrates non-obviousness, supported by experimental data or unique structural features.
  • Industrial applicability: The invention is suited for commercial development, fulfilling patent law requirements.

Timelines and Patent Status

WO2020039263 is a published application, not an granted patent. The application has a 20-year term from its priority date if granted.

  • Examination status: Pending or granted status varies by jurisdiction.
  • Potential oppositions or challenges: Common in competitive fields, affecting patent enforceability.

Strategic Considerations

For licensees or competitors:

  • Freedom to operate depends on the scope and validity of these claims.
  • Enforcement strategies focus on the specific claims' validity and scope.
  • Patent life: Filing timing and future extensions influence market exclusivity.

Key Takeaways

  • WO2020039263 claims a potentially broad set of pharmaceutical compositions or methods.
  • Claim language determines the scope; narrower claims are easier to defend but limit coverage.
  • The patent landscape involves multiple jurisdictions with variations in claim scope.
  • Prior art searches show the invention's novelty hinges on specific structural or functional features.
  • The application’s status remains pending; commercial enforcement depends on patent grant and claims validity.

FAQs

1. How does claim scope affect potential licensing negotiations?
Broader claims allow for wider licensing but face higher invalidation risks; narrower claims provide more defensible rights but limit scope.

2. What are the risks of patent invalidation in this case?
Prior art disclosures or obvious structural modifications can challenge the patent’s novelty or inventive step.

3. How can competitors navigate WO2020039263?
By analyzing claim language carefully, identifying any prior art overlaps, and considering alternative compounds or delivery methods.

4. When will this patent likely be granted?
It depends on the examination process in each jurisdiction, which can take 2–5 years; the application is still under examination.

5. What is the significance of filing in multiple jurisdictions?
It secures patent rights in key markets, with differences allowing strategic protection or potential license revenue.

References

  1. World Intellectual Property Organization. (2020). WO2020039263 patent application.
  2. European Patent Office. (2019). Patent classification and claim drafting.
  3. U.S. Patent and Trademark Office. (2021). Patent examination guidelines.
  4. Chinese Patent Office. (2020). Patent search and prior art considerations.
  5. Japan Patent Office. (2022). Patent prosecution procedures.

[1] WIPO. (2020). WO2020039263. Patent Application. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020039263

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.